Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases. Ettari R, Previti S, Bitto A, Grasso S, Zappalà M Curr Med Chem. 2016 Mar 18. PMID: 26965184. Abstract CommentRecommendBookmarkWatch